Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jiujiang Shanshui Technology
301190
5
LINTEX
920106
US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 0.6460
- -0.0370-5.42%
Close Apr 16 16:00 ET
- 0.6460
- 0.00000.00%
Post 20:01 ET
46.22MMarket Cap-2.00P/E (TTM)
0.6830High0.6174Low53.72KVolume0.6800Open0.6830Pre Close35.36KTurnover0.98%Turnover RatioLossP/E (Static)71.55MShares49.000052wk High1.12P/B3.55MFloat Cap0.550652wk Low--Dividend TTM5.50MShs Float49.0000Historical High--Div YieldTTM9.61%Amplitude0.5506Historical Low0.6580Avg Price1Lot Size
Citius Oncology Key Stats
EPS
According to the latest financial report of Citius Oncology, the latest earnings per share (TTM) for the company is -0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Citius Oncology's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Citius Oncology shows that the company's current ratio is 0.39, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Citius Oncology, the quick ratio is 0.00, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Citius Oncology? The latest ROE figure is -15.23%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Citius Oncology, the total asset return on investment (ROA) is -7.62%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Citius Oncology's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Citius Oncology, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
